KA
ARKG icon

Kovack Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Kovack Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$200K Buy
+4,704
New +$150K 0.01% 998
2024
Q4 		– Sell
-12,109
Closed -$310K – 613
2024
Q3 		$310K Sell
12,109
-1,023
-8% -$26K 0.03% 431
2024
Q2 		$308K Sell
13,132
-1,079
-8% -$27.2K 0.03% 413
2024
Q1 		$409K Sell
14,211
-128
-0.9% -$3.85K 0.05% 292
2023
Q4 		$470K Buy
14,339
+466
+3% +$12.7K 0.06% 310
2023
Q3 		$387K Buy
13,873
+830
+6% +$27.1K 0.05% 324
2023
Q2 		$445K Sell
13,043
-221
-2% -$6.95K 0.06% 319
2023
Q1 		$399K Buy
13,264
+911
+7% +$28.2K 0.05% 335
2022
Q4 		$349K Sell
12,353
-230
-2% -$7.3K 0.05% 371
2022
Q3 		$414K Sell
12,583
-73
-0.6% -$2.68K 0.06% 326
2022
Q2 		$399K Sell
12,656
-613
-5% -$21.4K 0.05% 376
2022
Q1 		$609K Sell
13,269
-37
-0.3% -$1.76K 0.06% 339
2021
Q4 		$815K Buy
13,306
+6,492
+95% +$449K 0.08% 277
2021
Q3 		$509K Buy
6,814
+758
+13% +$63.6K 0.06% 374
2021
Q2 		$560K Buy
6,056
+1,140
+23% +$96.9K 0.06% 327
2021
Q1 		$436K Buy
+4,916
New +$488K 0.06% 349
2020
Q3 		– Sell
-4,939
Closed -$258K – 529
2020
Q2 		$258K Sell
4,939
-19,461
-80% -$835K 0.05% 352
2020
Q1 		$763K Buy
24,400
+349
+1% +$11.7K 0.18% 135
2019
Q4 		$806K Buy
24,051
+2,217
+10% +$70.4K 0.14% 169
2019
Q3 		$645K Buy
21,834
+14,920
+216% +$485K 0.13% 182
2019
Q2 		$238K Buy
+6,914
New +$222K 0.05% 354
2018
Q2 		– Sell
-10,204
Closed -$263K – 432
2018
Q1 		$263K Buy
+10,204
New +$276K 0.07% 346

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Kovack Advisors's ARKG Position: Q2 2026 in Review

Kovack Advisors opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 4,704 shares worth $200K. The stake represents 0.01% of the portfolio and ranks #998 among its holdings. This is a return to the name: Kovack Advisors previously reported a position in ARKG as recently as Q3 2024.

Kovack Advisors first reported a position in ARKG in Q1 2018 and has held it in 22 quarters since. The position peaked at $815K in Q4 2021. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Kovack Advisors held 4,704 shares of ARK Genomic Revolution ETF worth $200K as of Q2 2026.
  • ARK Genomic Revolution ETF was a new Kovack Advisors position in Q2 2026.
  • ARK Genomic Revolution ETF made up 0.01% of Kovack Advisors's portfolio in Q2 2026, its #998 holding.
  • Kovack Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2018 and has held it in 22 quarters since.
  • Kovack Advisors's ARK Genomic Revolution ETF position peaked at $815K in Q4 2021.
  • 272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Kovack Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.